A multicentre validation study of the diagnostic value of plasma neurofilament lightNicholas J. Ashton, Oskar Hansson, Sebastian Palmqvist et al.|Nature Communications|2021Cited by 554
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive declineRik Ossenkoppele, Oskar Hansson, Alexa Pichet Binette et al.|Nature Medicine|2022Cited by 483
Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid testsNicolas R Barthélemy, Oskar Hansson, Gemma Salvadó et al.|Nature Medicine|2024Cited by 401
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary CareSebastian Palmqvist, Oskar Hansson, Pontus Tideman et al.|JAMA|2024Cited by 317
Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma BiomarkersNiklas Mattsson, Oskar Hansson, Gemma Salvadó et al.|JAMA Neurology|2023Cited by 293